Qin Cao
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Qin Cao has a total of 115 co-authors. Here are the top co-authors by number of shared publications:
- David S. Eisenberg
UCLA
10 shared publications - Michael R. Sawaya
Department of Chemistry and Biochemistry, University of California, Los Angeles
8 shared publications - David R. Boyer
University of California Los Angeles
6 shared publications - Jianting Han
Bio-X institutes, Key Laboratory for the Genetics of Developmental and Neuropsychiatric Disorders, Ministry of Education, Shanghai Jiao Tong University, Shanghai, China
6 shared publications Meinai Song
Key Laboratory for the Genetics of Developmental and Neuropsychiatric Disorders, Bio-X Institutes, Ministry of Education, Shanghai Jiao Tong University, Shanghai, China
5 shared publications- Chen Li
Network and Information Center, Shanghai Jiao Tong University, Shanghai, China
3 shared publications
Latest Publications
- Open Access
- 12 November 2026
- Published by Elsevier in Cell Reports
- Vol. 45 (11)
Cryo-EM structure of RegIIIγ filaments reveals the molecular basis of its bactericidal activity
- 12 November 2026
- Published by Elsevier in Cell Reports
- Vol. 45 (11)
Open AccessCryo-EM structure of RegIIIγ filaments reveals the molecular basis of its bactericidal activity
- Open Access
- 2 September 2026
- Published by Springer Nature in Communications Chemistry
Structural basis of synthetic Aβ fibrils with Flemish or Italian mutations
- 2 September 2026
- Published by Springer Nature in Communications Chemistry
Open AccessStructural basis of synthetic Aβ fibrils with Flemish or Italian mutations
- Open Access
- 12 June 2026
- Published by Wiley in Advanced Science
- Vol. 13 (50) , e76092
Hemoglobin's α‐Helix‐to‐β‐Sheet Transition Enables Targeted mRNA Delivery to the Lung
Effective treatment of pulmonary diseases remains constrained by the scarcity of delivery systems capable of selective tissue targeting. Herein, we report a lung‐targeting platform created through the structural repurposing of hemoglobin (Hb). Acidic heating enables a conformational shift of Hb from α‐helix to β‐sheet, leading to its self‐assembly into fibrils (HbFs). Unexpectedly, intravenously injected HbFs exhibit rapid and specific accumulation in the lungs. Cryo‐electron microscopy (cryo‐EM) structure determination revealed a fibril surface rich in positively charged residues, which facilitates two key functions: selective binding to circulating platelets via a hitchhiking mechanism for lung targeting, and efficient electrostatic complexation with mRNA. In a therapeutic application, HbFs loaded with mRNA encoding an interleukin‐11 single‐chain fragment variable (IL‐11 scFv) were administered in a murine model of bleomycin‐induced pulmonary fibrosis. The formulation achieved lung‐specific delivery with predominant uptake by pulmonary fibroblasts, enabling sustained local IL‐11 scFv expression. Consequently, treatment significantly suppressed fibroblast activation and migration, attenuated collagen deposition, restored lung function. This work establishes HbFs as a novel protein‑based vehicle for targeted mRNA delivery, leveraging natural cellular trafficking pathways to enable localized therapy for lung disorders.
- 12 June 2026
- Published by Wiley in Advanced Science
- Vol. 13 (50) , e76092
Open AccessHemoglobin's α‐Helix‐to‐β‐Sheet Transition Enables Targeted mRNA Delivery to the Lung
Effective treatment of pulmonary diseases remains constrained by the scarcity of delivery systems capable of selective tissue targeting. Herein, we report a lung‐targeting platform created through the structural repurposing of hemoglobin (Hb). Acidic heating enables a conformational shift of Hb from α‐helix to β‐sheet, leading to its self‐assembly into fibrils (HbFs). Unexpectedly, intravenously injected HbFs exhibit rapid and specific accumulation in the lungs. Cryo‐electron microscopy (cryo‐EM) structure determination revealed a fibril surface rich in positively charged residues, which facilitates two key functions: selective binding to circulating platelets via a hitchhiking mechanism for lung targeting, and efficient electrostatic complexation with mRNA. In a therapeutic application, HbFs loaded with mRNA encoding an interleukin‐11 single‐chain fragment variable (IL‐11 scFv) were administered in a murine model of bleomycin‐induced pulmonary fibrosis. The formulation achieved lung‐specific delivery with predominant uptake by pulmonary fibroblasts, enabling sustained local IL‐11 scFv expression. Consequently, treatment significantly suppressed fibroblast activation and migration, attenuated collagen deposition, restored lung function. This work establishes HbFs as a novel protein‑based vehicle for targeted mRNA delivery, leveraging natural cellular trafficking pathways to enable localized therapy for lung disorders.
- Open Access
- 28 April 2026
- Published by Springer Nature in Nature Communications
- Vol. 17 (1)
Ultrastructural and atomic characterization of biofilm-associated extracellular filaments in Shewanella oneidensis MR-1
Biofilms formed by Shewanella oneidensis MR-1 are crucial for metal reduction, underpinning bioremediation and bioenergy applications, yet detailed structural insights into biofilm components remain limited. Here we show that MR-1 biofilms contain abundant filamentous networks, membrane vesicles, and distinct square-shaped aggregates, as revealed by cryo-electron tomography and cryo-electron microscopy. We further determine near-atomic resolution structures of three filament types: bacterial flagella and two distinct pili, PilA and MshA. We present high-resolution structures of an MshA pilus and a PilA pilus from Shewanella. Structural analyses show that MshA pili exhibit a balanced surface charge distribution and extensive solvent-accessible surface area, facilitating essential interactions within the biofilm matrix. Additionally, oxygen limitation markedly increases the abundance of extracellular filaments and protein aggregates, indicating adaptive responses to environmental stress. Our findings elucidate the fundamental architecture and roles of biofilm extracellular components and provide a structural foundation for engineering enhanced Shewanella strains.
- 28 April 2026
- Published by Springer Nature in Nature Communications
- Vol. 17 (1)
Open AccessUltrastructural and atomic characterization of biofilm-associated extracellular filaments in Shewanella oneidensis MR-1
Biofilms formed by Shewanella oneidensis MR-1 are crucial for metal reduction, underpinning bioremediation and bioenergy applications, yet detailed structural insights into biofilm components remain limited. Here we show that MR-1 biofilms contain abundant filamentous networks, membrane vesicles, and distinct square-shaped aggregates, as revealed by cryo-electron tomography and cryo-electron microscopy. We further determine near-atomic resolution structures of three filament types: bacterial flagella and two distinct pili, PilA and MshA. We present high-resolution structures of an MshA pilus and a PilA pilus from Shewanella. Structural analyses show that MshA pili exhibit a balanced surface charge distribution and extensive solvent-accessible surface area, facilitating essential interactions within the biofilm matrix. Additionally, oxygen limitation markedly increases the abundance of extracellular filaments and protein aggregates, indicating adaptive responses to environmental stress. Our findings elucidate the fundamental architecture and roles of biofilm extracellular components and provide a structural foundation for engineering enhanced Shewanella strains.
- Open Access
- 3 February 2026
- Published by Springer Nature in Communications Chemistry
- Vol. 9 (1)
Structural basis for human RegⅢα filament formation
RegIIIα is an antibacterial protein primarily operating in the digestive tract to defend against bacterial infection through direct bactericidal activity. A previous study proposed that RegIIIα forms hexameric pores on the membrane of Gram-positive bacteria, leading to cell lysis. These RegIIIα hexamers can further assemble into filaments, diminishing RegIIIα activity. However, the high-resolution structure of RegIIIα assembly remains elusive, impeding the comprehension of the molecular mechanisms underlying RegIIIα function. In this study, we determined the cryo-electron microscopy (cryo-EM) structure of RegIIIα filaments formed in vitro at a resolution of 2.2 Å. Our structure reveals a similar subunit arrangement but a distinct subunit orientation compared to the previously reported low-resolution model of RegIIIα filaments. Through structural analysis and biochemical assays, we identified two essential interfaces for RegIIIα assembly, offered a potential explanation for the necessity of lipids in RegIIIα assembly, and elucidated the inhibitory mechanism of the pro-segment of RegIIIα. Collectively, our study presents the first near-atomic structure of filaments formed by C-tyle lectin containing proteins, providing structural insights into RegIIIα assembly that are closely related to its physiological functions and regulations.
- 3 February 2026
- Published by Springer Nature in Communications Chemistry
- Vol. 9 (1)
Open AccessStructural basis for human RegⅢα filament formation
RegIIIα is an antibacterial protein primarily operating in the digestive tract to defend against bacterial infection through direct bactericidal activity. A previous study proposed that RegIIIα forms hexameric pores on the membrane of Gram-positive bacteria, leading to cell lysis. These RegIIIα hexamers can further assemble into filaments, diminishing RegIIIα activity. However, the high-resolution structure of RegIIIα assembly remains elusive, impeding the comprehension of the molecular mechanisms underlying RegIIIα function. In this study, we determined the cryo-electron microscopy (cryo-EM) structure of RegIIIα filaments formed in vitro at a resolution of 2.2 Å. Our structure reveals a similar subunit arrangement but a distinct subunit orientation compared to the previously reported low-resolution model of RegIIIα filaments. Through structural analysis and biochemical assays, we identified two essential interfaces for RegIIIα assembly, offered a potential explanation for the necessity of lipids in RegIIIα assembly, and elucidated the inhibitory mechanism of the pro-segment of RegIIIα. Collectively, our study presents the first near-atomic structure of filaments formed by C-tyle lectin containing proteins, providing structural insights into RegIIIα assembly that are closely related to its physiological functions and regulations.
- Open Access
- 10 January 2026
- Published by Springer Nature in Molecular Neurodegeneration
- Vol. 21 (1)
The molecular fidelity of Aβ pathology in 5xFAD and AppNL−FPsen1P117L mice revealed by cryo-EM
Animal models, particularly mouse models, are indispensable for understanding the pathogenic mechanisms and developing therapeutic and diagnostic drugs for Alzheimer’s diseases (AD). While most AD mouse models aim to mimic amyloid-β (Aβ) pathology in their brains, previous research has demonstrated that not all models succeed in reproducing Aβ fibril structures observed in the brains of AD patients. In this study, we determined cryo-electron microscopy (cryo-EM) structures of Aβ fibrils extracted from the brains of two AD models, 5xFAD and App NL−F Psen1 P117L . The former represents one of the most widely used transgenic AD models, while the latter is the third-generation knock-in model designed to address the issues arising from App overexpression in conventional models. Our results revealed that fibrils from the 5xFAD mouse exhibit a structure nearly identical to human Type II Aβ fibrils found in AD patients, whereas the App NL−F Psen1 P117L mouse predominantly possesses Type II Aβ fibrils but also contains another Aβ fibril species. A subtle discrepancy in main chain arrangement at the position of Val36 was noted among all reported human and mouse Type II structures, potentially originating from variations in the brain microenvironment between human and mice. In conclusion, our findings validated the replication of Aβ pathology in 5xFAD and App NL−F Psen1 P117L mice and provide additional options for selecting appropriate animal models in studies necessitating molecular-level replication of Aβ structures.
- 10 January 2026
- Published by Springer Nature in Molecular Neurodegeneration
- Vol. 21 (1)
Open AccessThe molecular fidelity of Aβ pathology in 5xFAD and AppNL−FPsen1P117L mice revealed by cryo-EM
Animal models, particularly mouse models, are indispensable for understanding the pathogenic mechanisms and developing therapeutic and diagnostic drugs for Alzheimer’s diseases (AD). While most AD mouse models aim to mimic amyloid-β (Aβ) pathology in their brains, previous research has demonstrated that not all models succeed in reproducing Aβ fibril structures observed in the brains of AD patients. In this study, we determined cryo-electron microscopy (cryo-EM) structures of Aβ fibrils extracted from the brains of two AD models, 5xFAD and App NL−F Psen1 P117L . The former represents one of the most widely used transgenic AD models, while the latter is the third-generation knock-in model designed to address the issues arising from App overexpression in conventional models. Our results revealed that fibrils from the 5xFAD mouse exhibit a structure nearly identical to human Type II Aβ fibrils found in AD patients, whereas the App NL−F Psen1 P117L mouse predominantly possesses Type II Aβ fibrils but also contains another Aβ fibril species. A subtle discrepancy in main chain arrangement at the position of Val36 was noted among all reported human and mouse Type II structures, potentially originating from variations in the brain microenvironment between human and mice. In conclusion, our findings validated the replication of Aβ pathology in 5xFAD and App NL−F Psen1 P117L mice and provide additional options for selecting appropriate animal models in studies necessitating molecular-level replication of Aβ structures.
- Open Access
- 29 August 2025
- Published by Wiley in Advanced Science
- Vol. 12 (41) , e09821
Dual Hydrophilic‐Hydrophobic Core Architecture in Soy Glycinin Amyloid Fibrils Revealed by Cryo‐EM
Plant‐derived amyloid fibrils represent a promising class of sustainable nanomaterials outperforming their native counterparts in functionalities; however, the atomic‐level structural mechanisms behind these enhancements have yet to be elucidated. Using cryo‐EM, near‐atomic resolution structures (3.4 and 3.5 Å) are determined for two distinct fibril polymorphs assembled in vitro from soy glycinin‐A subunit. The dominant Type I fibril exhibits an unprecedented dual‐core architecture, characterized by spatially segregated hydrophilic (Asp172‐Asn178/Asn178’‐Asp172’) and hydrophobic (Val166‐Ile168/Val186’‐Pro184’) domains, which contribute to a unique amyloid fold distinct from many known amyloid structures, including pathological and functional amyloids. In contrast, the minor Type II fibril adopts a conventional extended hydrophobic core with Tyr155‐Tyr158 π‐stacking. These atomic structures establish fundamental structure‐property relationships that will inform the rational design of plant protein‐based nanomaterials.
- 29 August 2025
- Published by Wiley in Advanced Science
- Vol. 12 (41) , e09821
Open AccessDual Hydrophilic‐Hydrophobic Core Architecture in Soy Glycinin Amyloid Fibrils Revealed by Cryo‐EM
Plant‐derived amyloid fibrils represent a promising class of sustainable nanomaterials outperforming their native counterparts in functionalities; however, the atomic‐level structural mechanisms behind these enhancements have yet to be elucidated. Using cryo‐EM, near‐atomic resolution structures (3.4 and 3.5 Å) are determined for two distinct fibril polymorphs assembled in vitro from soy glycinin‐A subunit. The dominant Type I fibril exhibits an unprecedented dual‐core architecture, characterized by spatially segregated hydrophilic (Asp172‐Asn178/Asn178’‐Asp172’) and hydrophobic (Val166‐Ile168/Val186’‐Pro184’) domains, which contribute to a unique amyloid fold distinct from many known amyloid structures, including pathological and functional amyloids. In contrast, the minor Type II fibril adopts a conventional extended hydrophobic core with Tyr155‐Tyr158 π‐stacking. These atomic structures establish fundamental structure‐property relationships that will inform the rational design of plant protein‐based nanomaterials.
- Open Access
- 6 August 2025
- Published by Springer Nature in Communications Chemistry
- Vol. 8 (1) , 1-9
Cryo-EM structure of amyloid fibrils formed by full-length human αA-crystallin with pathogenic mutation R116C
The aggregation of crystallin proteins in human lens is the primary cause of cataracts, a disease that leads to blindness of tens of millions of people worldwide. Understanding the molecular architectures of these aggregated crystallin proteins can facilitate the development of therapeutic drugs to treat cataract without surgery. In this study, we prepared two types of crystallin fibrils, thick and thin, using recombinant human αA-crystallin harboring the disease-associated R116C mutation under neutral and acidic conditions, respectively. The structure of the thin fibrils was determined via cryo-EM at a resolution of 3.7 Å, whereas the thick fibrils appeared unsuitable for cryo-EM structure determination. Structure analysis suggests that the thin fibrils adopt a three-layered structure stabilized by extensive steric zipper interactions. The observation of aspartate and glutamate ladders stacking along the fibril axis is consistent with the preference for an acidic environment of the thin fibrils. Disease mutations on Arg49 and Arg54 appear to facilitate the fibril structure, suggesting the potential disease relevance of these fibrils. Taken together, our study provides the first near-atomic resolution structure of aggregated crystallin and may facilitate the future studies on the mechanism and therapeutic of cataracts.
- 6 August 2025
- Published by Springer Nature in Communications Chemistry
- Vol. 8 (1) , 1-9
Open AccessCryo-EM structure of amyloid fibrils formed by full-length human αA-crystallin with pathogenic mutation R116C
The aggregation of crystallin proteins in human lens is the primary cause of cataracts, a disease that leads to blindness of tens of millions of people worldwide. Understanding the molecular architectures of these aggregated crystallin proteins can facilitate the development of therapeutic drugs to treat cataract without surgery. In this study, we prepared two types of crystallin fibrils, thick and thin, using recombinant human αA-crystallin harboring the disease-associated R116C mutation under neutral and acidic conditions, respectively. The structure of the thin fibrils was determined via cryo-EM at a resolution of 3.7 Å, whereas the thick fibrils appeared unsuitable for cryo-EM structure determination. Structure analysis suggests that the thin fibrils adopt a three-layered structure stabilized by extensive steric zipper interactions. The observation of aspartate and glutamate ladders stacking along the fibril axis is consistent with the preference for an acidic environment of the thin fibrils. Disease mutations on Arg49 and Arg54 appear to facilitate the fibril structure, suggesting the potential disease relevance of these fibrils. Taken together, our study provides the first near-atomic resolution structure of aggregated crystallin and may facilitate the future studies on the mechanism and therapeutic of cataracts.
- Open Access
- 23 June 2025
- Published by Public Library of Science (PLoS) in PLOS Biology
- Vol. 23 (6) , e3003238
Structure of human glycoprotein 2 reveals mechanisms underlying filament formation and adaption to proteolytic environment in the digestive tract
Glycoprotein 2 (GP2) and Uromodulin (UMOD) are considered as paralogs that share high sequence similarity and have similar antibacterial functions. UMOD are abundant as filaments in the urinary tract, and a high-mannose N-glycosylation site located on the N-terminal region protruding from UMOD filament core (referred to as branch) acts as an adhesion antagonist against pathogenic bacterial infections. The antibacterial function of UMOD can be eliminated by proteases, as the UMOD branch is susceptible to proteolytic activity. GP2 is expressed in the pancreas and secreted into the digestive tract. Whether GP2 executes its function in filament form and how it remains functional in the protease-enriched digestive tract is unclear. In this study, we extract GP2 filaments from surgically excised human pancreas and determined their cryo-EM structure. Our structure analysis unveiled that GP2 forms filaments with its ZP modules, composing the ZPN and ZPC domains along with a linker that connects these two domains. The N-terminal region (branch) of GP2 does not constitute the filament core and appears flexible in the cryo-EM structure. Our biochemical experiments suggested that although the GP2 branch is also protease-susceptible, additional high-mannose N-glycans were identified on the protease-resistant GP2 filament core. Consequently, the branch-free GP2 filaments retain their binding ability to the bacterial adhesin FimH, ensuring GP2’s antibacterial function unaffected in the proteolytic environment. Our study provides the first experimental evidence of GP2 filament formation and reveals the molecular mechanisms underlying GP2’s adaptation to a different environment compared to UMOD.
- 23 June 2025
- Published by Public Library of Science (PLoS) in PLOS Biology
- Vol. 23 (6) , e3003238
Open AccessStructure of human glycoprotein 2 reveals mechanisms underlying filament formation and adaption to proteolytic environment in the digestive tract
Glycoprotein 2 (GP2) and Uromodulin (UMOD) are considered as paralogs that share high sequence similarity and have similar antibacterial functions. UMOD are abundant as filaments in the urinary tract, and a high-mannose N-glycosylation site located on the N-terminal region protruding from UMOD filament core (referred to as branch) acts as an adhesion antagonist against pathogenic bacterial infections. The antibacterial function of UMOD can be eliminated by proteases, as the UMOD branch is susceptible to proteolytic activity. GP2 is expressed in the pancreas and secreted into the digestive tract. Whether GP2 executes its function in filament form and how it remains functional in the protease-enriched digestive tract is unclear. In this study, we extract GP2 filaments from surgically excised human pancreas and determined their cryo-EM structure. Our structure analysis unveiled that GP2 forms filaments with its ZP modules, composing the ZPN and ZPC domains along with a linker that connects these two domains. The N-terminal region (branch) of GP2 does not constitute the filament core and appears flexible in the cryo-EM structure. Our biochemical experiments suggested that although the GP2 branch is also protease-susceptible, additional high-mannose N-glycans were identified on the protease-resistant GP2 filament core. Consequently, the branch-free GP2 filaments retain their binding ability to the bacterial adhesin FimH, ensuring GP2’s antibacterial function unaffected in the proteolytic environment. Our study provides the first experimental evidence of GP2 filament formation and reveals the molecular mechanisms underlying GP2’s adaptation to a different environment compared to UMOD.